Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer

WVNews | Business

Feb 4, 2019

BOSTON--(BUSINESS WIRE)--Feb 4, 2019--Kyn Therapeutics, a clinical-stage biotechnology company developing new immunometabolic therapies for treating cancer, today announced that it…